BR0305436A - Utilização de pelo menos um fragmento polinucleotìdico e de uma combinação de pelo menos dois fragmentos poliniucleotìdicos, processo para o diagnóstico de uma predisposição a encanecimento precoce em um indivìduo, e, kit - Google Patents

Utilização de pelo menos um fragmento polinucleotìdico e de uma combinação de pelo menos dois fragmentos poliniucleotìdicos, processo para o diagnóstico de uma predisposição a encanecimento precoce em um indivìduo, e, kit

Info

Publication number
BR0305436A
BR0305436A BR0305436-5A BR0305436A BR0305436A BR 0305436 A BR0305436 A BR 0305436A BR 0305436 A BR0305436 A BR 0305436A BR 0305436 A BR0305436 A BR 0305436A
Authority
BR
Brazil
Prior art keywords
early
genes
human chromosome
gene selected
whose sequence
Prior art date
Application number
BR0305436-5A
Other languages
English (en)
Inventor
Olivier De Lacharriere
Jean-Louis Blouin
Claire Deloche
Stylianos Antonarakis
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of BR0305436A publication Critical patent/BR0305436A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/148—Screening for cosmetic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"UTILIZAçãO DE PELO MENOS UM FRAGMENTO POLINUCLEOTìDICO E DE UMA COMBINAçãO DE PELO MENOS DOIS FRAGMENTOS POLINUCLEOTìDICOS, PROCESSO PARA O DIAGNóSTICO DE UMA PREDISPOSIçãO AO ENCANECIMENTO PRECOCE EM UM INDIVìDUO, E, KIT". Utilização de pelo menos um fragmento polinucleotídico compreendendo pelo menos 18 nucleotídeos consecutivos cuja seq³ência corresponde a todo a parte de um gene do cromossomo 3 humano selecionado dentre os genes KIAA1042, CCK, CACNA1D, ARHGEF3 e AL133097, ou cuja seq³ência corresponde a todo a parte de um gene do cromossomo 5 humano selecionado dentre os genes KLHL3, HNRPA0, CDC25C, EGR1, C5orf6, C5orf7, LOC51308, ETF1, HSPA9B, PCDHA1 a PCDHA13, CSF1R, RPL7, PDGFRB, TCOF1, AL133039, CD74, RPSI4, NDST1, G3BP, GLRA1, C5orf3, MFAP3, GALNT10 e FLJ11715, ou cuja seq³ência corresponde a todo a parte de um gene do cromossomo 11 humano selecionado dentre os genes GUCY1A2, CUL5, ACATI, NPAT, ATM, AF035326, AF035327, AF035328, BC029536, FLJ20535, DRD2, ENS303941, IGSF4, LOC51092, BC010946, TAGLN, PCSK7 e ENS300650, utilização de agentes capazes de modificar a função ligada a uma destas regiões, utilização dos produtos de expressão de uma destas regiões e utilização de agentes capazes de modificar a função destes produtos de expressão, para fins cosméticos, terapêuticos ou diagnósticos.
BR0305436-5A 2002-07-10 2003-07-09 Utilização de pelo menos um fragmento polinucleotìdico e de uma combinação de pelo menos dois fragmentos poliniucleotìdicos, processo para o diagnóstico de uma predisposição a encanecimento precoce em um indivìduo, e, kit BR0305436A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0208697A FR2842105B1 (fr) 2002-07-10 2002-07-10 Localisation des genes impliques dans la canitie precoce
PCT/FR2003/002153 WO2004007764A2 (fr) 2002-07-10 2003-07-09 Genes des chromosomes 3,5 et 11 impliques dans la canitie precoce

Publications (1)

Publication Number Publication Date
BR0305436A true BR0305436A (pt) 2004-09-28

Family

ID=29763718

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0305436-5A BR0305436A (pt) 2002-07-10 2003-07-09 Utilização de pelo menos um fragmento polinucleotìdico e de uma combinação de pelo menos dois fragmentos poliniucleotìdicos, processo para o diagnóstico de uma predisposição a encanecimento precoce em um indivìduo, e, kit

Country Status (7)

Country Link
EP (1) EP1520042A2 (pt)
JP (1) JP2005532407A (pt)
AU (1) AU2003267513A1 (pt)
BR (1) BR0305436A (pt)
CA (1) CA2491235A1 (pt)
FR (1) FR2842105B1 (pt)
WO (1) WO2004007764A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2864899A1 (fr) * 2004-01-08 2005-07-15 Oreal Differents genes impliques dans la canitie precoce
WO2005068650A2 (en) * 2004-01-08 2005-07-28 L'oreal Various human chromosomal regions implicated in premature canities
RU2437212C2 (ru) 2006-11-06 2011-12-20 Квэлкомм Инкорпорейтед Способы и устройство для распределения мощности и/или выбора скорости передачи для операций mimo/simo восходящей линии с учетом par
FR2930775B1 (fr) 2008-04-30 2010-05-21 Oreal Utilisations de bnipxl-beta dans la canitie precoce
JP5695384B2 (ja) 2009-10-05 2015-04-01 花王株式会社 毛髪形状感受性遺伝子
JP5695383B2 (ja) 2009-10-05 2015-04-01 花王株式会社 毛髪形状感受性遺伝子
JP5695385B2 (ja) 2009-10-05 2015-04-01 花王株式会社 毛髪形状感受性遺伝子

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470577A (en) * 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US5858661A (en) * 1995-05-16 1999-01-12 Ramot-University Authority For Applied Research And Industrial Development Ataxia-telangiectasia gene and its genomic organization
WO2000047770A1 (en) * 1999-02-15 2000-08-17 Catalyst Biomedica Ltd. Susceptibility locus for osteoarthritis

Also Published As

Publication number Publication date
AU2003267513A8 (en) 2004-02-02
FR2842105A1 (fr) 2004-01-16
FR2842105B1 (fr) 2012-12-28
WO2004007764A3 (fr) 2004-04-08
AU2003267513A1 (en) 2004-02-02
CA2491235A1 (fr) 2004-01-22
EP1520042A2 (fr) 2005-04-06
JP2005532407A (ja) 2005-10-27
WO2004007764A2 (fr) 2004-01-22

Similar Documents

Publication Publication Date Title
Lim et al. The saliva microbiome profiles are minimally affected by collection method or DNA extraction protocols
Geisler et al. Frequency of BRCA1 dysfunction in ovarian cancer
Kader et al. DNA methylation and application in forensic sciences
Strunnikova et al. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter
Bender et al. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas
Hagemann et al. Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines
Wei et al. Estrogen receptor α, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers
Jessie et al. Accumulation of mitochondrial DNA deletions in the malignant prostate of patients of different ages
Ando et al. Decitabine (5-Aza-2′-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells
Maeda et al. Comprehensive and quantitative multilocus methylation analysis reveals the susceptibility of specific imprinted differentially methylated regions to aberrant methylation in Beckwith–Wiedemann syndrome with epimutations
JP2012501183A (ja) 皮膚サンプルの年齢範囲の決定方法
JP2004033215A5 (pt)
BR0305436A (pt) Utilização de pelo menos um fragmento polinucleotìdico e de uma combinação de pelo menos dois fragmentos poliniucleotìdicos, processo para o diagnóstico de uma predisposição a encanecimento precoce em um indivìduo, e, kit
Williams et al. High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines
Andia et al. DNA methylation analysis of SOCS1, SOCS3, and LINE-1 in microdissected gingival tissue
Mühlisch et al. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood
Correia Dias et al. DNA methylation age estimation from human bone and teeth
Carpentier et al. Association of telomerase gene hTERT polymorphism and malignant gliomas
Locke et al. Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls
Deichmann et al. PTEN/MMAC1 expression in melanoma resection specimens
Tsellou et al. Hypermethylation of CpG islands in the promoter region of the p15INK4B gene in childhood acute leukaemia
Collins et al. Methylation of death-associated protein kinase in ovarian carcinomas
Buyru et al. Methylation profiles in breast cancer
Scholl et al. Development of a real‐time RT‐PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t (9; 11)(p22; q23) in acute myeloid leukemia
JP2015038104A (ja) 若白髪に関与する染色体６及び９の遺伝子

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 6A ANUIDADE

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2047 DE 30/03/2010.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 5/06 (2006.01), A61K 8/60 (2006.01), A61Q 5/0